Rudy Dekeyser, PhD, joined LSP in 2012 and became Managing Partner of LSP’s Health Economics Fund in that same year. Rudy’s prime focus and responsibility within LSP is to invest in unlisted securities. Prior to joining LSP, Rudy was a co-founder of VIB in 1995 and Managing Director of the research institute for 17 years, where he was also responsible for all business development. Together with a highly professional team he managed to build a large patent estate, executed over 800 R&D and license agreements and established many biotech companies such as Devgen (acquired by Syngenta), CropDesign (acquired by BASF), Ablynx (listed on Nasdaq), Actogenix (acquired by Intrexon) and Multiplicom (acquired by Agilent). Rudy was a catalyst in the development of a strong cluster in Flanders by uniting the actors in the life sciences association FlandersBio, building bio-incubators and triggering the establishment of bio-accelerators. He has been chairman and non-executive director at many company boards and is currently board member at Curetis, Sequana Medical, reMYND and Celyad. He is chairman of EMBLEM (EMBL’s business arm) and is member of the supervisory/advisory board of several foundations active in advancing life sciences research and its translation into benefit for society. Rudy brings company building skills to the LSP team. Rudy has a Master’s degree in zoology and a PhD in molecular biology from the University of Gent. He lives near Gent with his wife, has two children and a growing number of grandchildren.
To contact Rudy directly, email email@example.com or call +32 (475) 95 11 97.